The
global Drug Discovery Informatics Market size is expected
to reach USD 2.07 billion by 2025, according to a new report by Grand View
Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug
therapy is evolving in response to health care needs of the population. The
most recent trend is to develop drugs for treatment of chronic diseases,
especially those affecting the older population.
Further key findings from the report suggest:
Cardiovascular
Diseases (CVDs), stroke, and cancer are the most prevalent health issues and
also the most common conditions causing death. Moreover, treatment expenses and
costs pertaining to these diseases are very high, which triggers the demand for
effective novel molecules. In the U.S. alone, revenue generated through CVD
treatments was over USD 444 billion in 2010, and it has been estimated to claim
more lives each year than the remaining causes of death combined.
Clinical
decision support tools, which include online database for assistance in
enhancement of clinical decisions, are timely updated and that significantly
impacts market growth. Moreover, the World Health Organization's Consultative
Expert Working Group for Research and Development is also involved in
evaluation and development of open source drug discovery platforms.
Introduction of open drug discovery tool kit (ODDT), which serves as a tool for
computer-aided drug discovery by implementing machine learning scoring
functions (RF-Score and NN-Score), is anticipated to work in favor of the
market.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market
Further key findings from the report suggest:
- Lead generation and lead
optimization are anticipated to witness hand-in-hand growth owing to usage
of similar IT solutions
- Presence of different
co-operation models, such as joint ventures, strategic partnership, price
competition, and project selection, for outsourcing drug informatics
solutions in the industry is influencing the growth of the market
positively
- North America is projected
to hold prominent position in the arena throughout the forecast period.
Higher incidence rates of different infectious diseases and oncology
diseases are expected to drive the demand for informatics solutions to aid
drug discovery and development. Presence of molecular R&D laboratories
and market players in the U.S. is supplementing the growth of the regional
market
- Asia Pacific is likely to
post the highest CAGR during the same period, owing to cost saving
advantage offered by the region
- Some of the key players
operating in the market Boehringer Ingelheim GmBh; ChemAxon; Jubilant
Biosys; Certara; Selvita; Novo Informatics; Albany Molecular Research
Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK
Biosciences; and Charles River Laboratories.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment